Adjuvant denosumab in postmenopausal patients with hormone receptor-positive breast cancer

被引：0
|
作者：
Lippman, Marc [1 ]
机构：
[1] Georgetown Univ, Dept Oncol, Washington, DC 20057 USA
来源：
LANCET ONCOLOGY | 2019年 / 20卷 / 03期
关键词：
D O I：
10.1016/S1470-2045(18)30913-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：312 / 313
页数：2
相关论文
共 50 条
  • [41] Pharmacogenomic prediction of breast cancer treatment outcome with adjuvant tamoxifen in postmenopausal women with estrogen receptor-positive breast cancer
    Pribylova, O.
    Petruzelka, L. B.
    Argalaczova, S.
    Konopasek, B.
    Drazdakova, J.
    Slanar, O.
    Slanar, O.
    Zima, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [42] Use of Adjuvant Endocrine Therapy in Postmenopausal Hormone Receptor-Positive Breast Cancer at German Breast Cancer Centers and University Hospitals - Results of an Enquiry (Adjuvant Endocrine Therapy Enquiry)
    Kolben, Thomas
    Engelmann, Susanne
    Maurer, Susanne
    Kolben, Martin
    BREAST CARE, 2012, 7 (01) : 39 - 44
  • [43] Effect of body mass index on the efficacy of adjuvant tamoxifen in premenopausal patients with hormone receptor-positive breast cancer
    Sendur, Mehmet A. N.
    Aksoy, Sercan
    Ozdemir, Nuriye Y.
    Zengin, Nurullah
    Yazici, Ozan
    Sever, Ali R.
    Altundag, Kadri
    JOURNAL OF BUON, 2016, 21 (01): : 27 - 34
  • [44] Adjuvant endocrine therapy is associated with improved overall survival in elderly hormone receptor-positive breast cancer patients
    Crystal, Jessica S.
    Rand, Jamie
    Johnson, Jeffrey
    Kim, Sungjin
    Basho, Reva
    Amersi, Farin
    Giuliano, Armando E.
    Chung, Alice
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 184 (01) : 63 - 74
  • [45] Prognostic factors of early distant recurrence in hormone receptor-positive, postmenopausal breast cancer patients receiving adjuvant tamoxifen therapy - Results of a retrospective analysis
    Debled, Marc
    MacGrogan, Gaetan
    Brouste, Veronique
    Mathoulin-Pelissier, Simone
    Durand, Michel
    Mauriac, Louis
    CANCER, 2007, 109 (11) : 2197 - 2204
  • [46] Efficacy of adjuvant tamoxifen in hormone receptor-positive premenopausal breast cancer patients according to the body mass index
    Altundag, Kadri
    Sendur, Mehmet A. N.
    Aksoy, Sercan
    Babacan, Taner
    Ozisik, Yavuz
    CANCER RESEARCH, 2015, 75
  • [47] Oncologists' Recommendations for Adjuvant Therapy in Hormone Receptor-Positive Breast Cancer Patients of Varying Age and Health Status
    Naeim, Arash
    Wong, F. Lennie
    Pal, Sumanta K.
    Hurria, Arti
    CLINICAL BREAST CANCER, 2010, 10 (02) : 136 - 143
  • [48] Controversies in oncology: which adjuvant endocrine therapy is to be given to premenopausal patients with hormone receptor-positive breast cancer?
    Lambertini, Matteo
    Viglietti, Giulia
    de Azambuja, Evandro
    ESMO OPEN, 2018, 3 (03)
  • [49] Adjuvant endocrine therapy is associated with improved overall survival in elderly hormone receptor-positive breast cancer patients
    Jessica S. Crystal
    Jamie Rand
    Jeffrey Johnson
    Sungjin Kim
    Reva Basho
    Farin Amersi
    Armando E. Giuliano
    Alice Chung
    Breast Cancer Research and Treatment, 2020, 184 : 63 - 74
  • [50] What Is the Optimal Endocrine Therapy for Postmenopausal Women With Hormone Receptor-Positive Early Breast Cancer?
    Tung, Nadine
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (11) : 1391 - 1397
12345